Literature DB >> 24639516

Tissue-specific tumor suppression by BRCA1.

Eva Y-H P Lee1, Serena Abbondante.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24639516      PMCID: PMC3970521          DOI: 10.1073/pnas.1403033111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

1.  Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells.

Authors:  Heather J Lee; David Gallego-Ortega; Anita Ledger; Daniel Schramek; Purna Joshi; Maria M Szwarc; Christina Cho; John P Lydon; Rama Khokha; Josef M Penninger; Christopher J Ormandy
Journal:  Development       Date:  2013-03-05       Impact factor: 6.868

Review 2.  53BP1, BRCA1, and the choice between recombination and end joining at DNA double-strand breaks.

Authors:  James M Daley; Patrick Sung
Journal:  Mol Cell Biol       Date:  2014-01-27       Impact factor: 4.272

3.  Estrogen controls the survival of BRCA1-deficient cells via a PI3K-NRF2-regulated pathway.

Authors:  Chiara Gorrini; Bevan P Gang; Christian Bassi; Andrew Wakeham; Shakiba Pegah Baniasadi; Zhenyue Hao; Wanda Y Li; David W Cescon; Yen-Ting Li; Sam Molyneux; Nadia Penrod; Mathieu Lupien; Edward E Schmidt; Vuk Stambolic; Mona L Gauthier; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

4.  Progesterone receptor A stability is mediated by glycogen synthase kinase-3β in the Brca1-deficient mammary gland.

Authors:  Shaohui Wang; Ying Li; Pang-Hung Hsu; Sou-Ying Lee; Yoon Kim; Eva Y-H P Lee
Journal:  J Biol Chem       Date:  2013-07-23       Impact factor: 5.157

Review 5.  Mouse models of BRCA1 and their application to breast cancer research.

Authors:  Jennifer Dine; Chu-Xia Deng
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

Review 6.  Progesterone signalling in breast cancer: a neglected hormone coming into the limelight.

Authors:  Cathrin Brisken
Journal:  Nat Rev Cancer       Date:  2013-06       Impact factor: 60.716

Review 7.  Triple-negative breast cancer: molecular subtypes and targeted therapy.

Authors:  Kim M Hirshfield; Shridar Ganesan
Journal:  Curr Opin Obstet Gynecol       Date:  2014-02       Impact factor: 1.927

8.  Alterations in Brca1 expression in mouse ovarian granulosa cells have short-term and long-term consequences on estrogen-responsive organs.

Authors:  Hai-Yun Yen; Yankel Gabet; Ying Liu; Anthony Martin; Nancy L Wu; Malcolm C Pike; Baruch Frenkel; Robert Maxson; Louis Dubeau
Journal:  Lab Invest       Date:  2012-04-09       Impact factor: 5.662

9.  BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.

Authors:  Chiara Gorrini; Pegah S Baniasadi; Isaac S Harris; Jennifer Silvester; Satoshi Inoue; Bryan Snow; Purna A Joshi; Andrew Wakeham; Sam D Molyneux; Bernard Martin; Peter Bouwman; David W Cescon; Andrew J Elia; Zoe Winterton-Perks; Jennifer Cruickshank; Dirk Brenner; Alan Tseng; Melinda Musgrave; Hal K Berman; Rama Khokha; Jos Jonkers; Tak W Mak; Mona L Gauthier
Journal:  J Exp Med       Date:  2013-07-15       Impact factor: 14.307

10.  The sex hormone system in carriers of BRCA1/2 mutations: a case-control study.

Authors:  Martin Widschwendter; Adam N Rosenthal; Sue Philpott; Ivana Rizzuto; Lindsay Fraser; Jane Hayward; Maria P Intermaggio; Christopher K Edlund; Susan J Ramus; Simon A Gayther; Louis Dubeau; Evangelia Ourania Fourkala; Alexey Zaikin; Usha Menon; Ian J Jacobs
Journal:  Lancet Oncol       Date:  2013-10-17       Impact factor: 41.316

View more
  9 in total

Review 1.  Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel "first-in-class" anti-inflammatory drug candidates: a reviewer's perspective.

Authors:  Geetha Mathew; M K Unnikrishnan
Journal:  Inflamm Res       Date:  2015-07-18       Impact factor: 4.575

2.  Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis.

Authors:  Xiaowen Zhang; Huai-Chin Chiang; Yao Wang; Chi Zhang; Sabrina Smith; Xiayan Zhao; Sreejith J Nair; Joel Michalek; Ismail Jatoi; Meeghan Lautner; Boyce Oliver; Howard Wang; Anna Petit; Teresa Soler; Joan Brunet; Francesca Mateo; Miguel Angel Pujana; Elizabeth Poggi; Krysta Chaldekas; Claudine Isaacs; Beth N Peshkin; Oscar Ochoa; Frederic Chedin; Constantine Theoharis; Lu-Zhe Sun; Tyler J Curiel; Richard Elledge; Victor X Jin; Yanfen Hu; Rong Li
Journal:  Nat Commun       Date:  2017-06-26       Impact factor: 14.919

3.  Gene-Specific Genetic Complementation between Brca1 and Cobra1 During Mouse Mammary Gland Development.

Authors:  Huai-Chin Chiang; Xiaowen Zhang; Xiayan Zhao; Chi Zhang; Jerry Chen; Paula Garza; Sabrina Smith; Thomas Ludwig; Richard J Baer; Rong Li; Yanfen Hu
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

4.  BRCA1-associated R-loop affects transcription and differentiation in breast luminal epithelial cells.

Authors:  Huai-Chin Chiang; Xiaowen Zhang; Jingwei Li; Xiayan Zhao; Jerry Chen; Howard T-H Wang; Ismail Jatoi; Andrew Brenner; Yanfen Hu; Rong Li
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

5.  The X-linked tumor suppressor TSPX downregulates cancer-drivers/oncogenes in prostate cancer in a C-terminal acidic domain dependent manner.

Authors:  Tatsuo Kido; Yunmin Li; Yuichiro Tanaka; Rajvir Dahiya; Yun-Fai Chris Lau
Journal:  Oncotarget       Date:  2019-02-19

Review 6.  Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies.

Authors:  Poornima Paramasivan; Ibrahim H Kankia; Simon P Langdon; Yusuf Y Deeni
Journal:  Cancer Drug Resist       Date:  2019-09-19

7.  Genetic suppression reveals DNA repair-independent antagonism between BRCA1 and COBRA1 in mammary gland development.

Authors:  Sreejith J Nair; Xiaowen Zhang; Huai-Chin Chiang; Md Jamiul Jahid; Yao Wang; Paula Garza; Craig April; Neeraj Salathia; Tapahsama Banerjee; Fahad S Alenazi; Jianhua Ruan; Jian-Bing Fan; Jeffrey D Parvin; Victor X Jin; Yanfen Hu; Rong Li
Journal:  Nat Commun       Date:  2016-03-04       Impact factor: 14.919

8.  MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.

Authors:  Barbara Bennani-Baiti; Matthias Dietzel; Pascal Andreas Baltzer
Journal:  PLoS One       Date:  2016-07-05       Impact factor: 3.240

Review 9.  MiRNAs: A Powerful Tool in Deciphering Gynecological Malignancies.

Authors:  Florentina Duică; Carmen Elena Condrat; Cezara Alina Dănila; Andreea Elena Boboc; Mihaela Raluca Radu; Junjie Xiao; Xinli Li; Sanda Maria Creţoiu; Nicolae Suciu; Dragoş Creţoiu; Dragoş-Valentin Predescu
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.